Close Menu

This article has been updated with additonal information from Courtagen Life Sciences and Medicinal Genomics.

NEW YORK (GenomeWeb) – Courtagen Life Sciences said today that it has closed its diagnostic neurology testing business. According to the firm's website, it no longer accepts patient samples. 

The company's wholly owned subsidiary, Medicinal Genomics Corporation (MGC), which provides cannabis genetics research and testing, will remain intact and Courtagen is taking on this name.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.